Connect with us
European Gaming Congress 2024

Artificial Intelligence

The market is expected to grow at a CAGR of 9.04% during the forecast period from 2021 to 2030

Published

on

New York, July 29, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Urology Care Devices and Platforms Market: Focus on Product Type, Application, Indication, End User, and Regional Analysis” – https://www.reportlinker.com/p06124032/?utm_source=GNW

• Product- Devices (Conventional Devices and Advanced Devices) and Platforms
• Application- Treatment and Diagnosis and Monitoring
• Indication- Kidney Diseases, Urological Cancer and Benign Prostatic Hyperlapsia, Pelvic Organ Prolapse, and Other Diseases
• End User- Hospitals, Ambulatory Surgery Centers, and Clinics, Dialysis Centers, and Home Care Settings

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, U.K, France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Argentina, and Rest-of-Latin-America
• Middle East and Africa – K.S.A., Israel, South Africa, and Rest-of-Middle East and Africa

Market Growth Drivers

• Rising Prevalence of Urological Disorders
• Rising Technology Integration in Urology Care
• Product Portfolio Expansion through Mergers and Acquisitions

Advertisement
Stake.com

Market Challenges

• High Upfront Cost of Devices
• Data Privacy Concerns

Market Opportunities

• Adoption of Telesurgery in Urology Care
• Emergence of Regional Companies in Global Urology Care Devices and Platforms Market
• Development of Remote Patient Monitoring Devices

Key Companies Profiled

Advertisement
Stake.com

Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, Urologix, LLC.

How This Report Can Add Value

Who should buy this report?

• Technology/non-healthcare companies planning to enter the urology market through a platform, mobile application, or smart device
• Urological device manufacturers
• AI-enabled platform developers
• Imaging modalities companies (specifically for urology)
• Endoscope manufacturers

Key questions answered in the Global Urology Care Devices and Platforms Market Report

Advertisement
Stake.com

• How has COVID-19 impacted the adoption of urology care devices and platforms applications?
• What are the key regulations governing the urology care devices and platforms market in key regions?
• What are the technological developments projected to have the maximum influence on the global urology care devices and platforms market?
• Who are the leading players holding significant dominance in the global urology care devices and platforms market currently?
• What are the drivers and restraints for the global urology care devices and platforms market?
• Which region has the highest growth rate in the urology care devices and platform market?
• Who are the key end-users of the global urology care devices and platform market?
• Which are the emerging companies in the global urology care devices and platforms market?

Global Urology Care Devices and Platforms Market Overview

The scope of the global urology care devices and platforms market involves conventional and advanced devices as well as platforms that are used in urological disease management.The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems.

Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology-enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.

The global urology care devices and platforms market comprises of various key medical device companies and emerging companies. The major medical device companies operating in the market include Baxter International Inc., Olympus Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, and Medtronic plc.

Advertisement
Stake.com

However, owing to the rising technology penetration and demand for minimally invasive procedures, various novel companies such as Axonics Modulation Technologies, Inc., Micron Medical Corporation, and robotic system companies such as Intuitive Surgical, Inc. have also entered the market and are offering advanced devices such as neurostimulators for urological treatment. Additionally, owing to the rising demand for remote patient monitoring and integration of digital solutions, emerging companies such as CareLogiQ Corp, Renalytix AI plc, and Healthy.io Ltd have entered the market and are projected to witness significant growth during the forecast period 2021-2030.

The pipeline of global urology care devices and platforms market primarily comprises advanced devices and platforms.Various companies such as Implantica AG, Micron Medical, Lucida Medical, and Neuspera Medical have products in the pipeline that are anticipated to be commercialized by the end of 2030.

The launch of these products is projected to propel technology integration in the urology care landscape.

The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions.The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns.

The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.

Advertisement
Stake.com

Key technology trends such as the switch from open procedures to minimally invasive procedures, inclusion of telemedicine in urology practices, remote patient monitoring devices, and integration of artificial intelligence (AI) for improved patient assessment are anticipated to influence the global urology care devices and platforms market.AI has been integrated into various healthcare applications for improved data analytics.

AI inclusion in diagnosis, medical imaging, data collection, result interpretation, and treatment planning has improved physician’s decision-making quality.

The global urology care devices and platforms market has witnessed significant technology integration in the past few years.There has been significant design- and product-level innovations in the market.

For instance, more than 5,100 patents have been filed from January 2015 -June 2021, with the highest number of filings in 2019 (1,792 patents).

During January 2018-June 2021, the global urology care devices and platforms market witnessed 50 key developments.Regulatory and legal activities were the most actively employed strategies, followed by mergers and acquisitions.

Advertisement
Stake.com

The key companies that received regulatory approvals between January 2018-June 2021 included Advanced MedTech Holdings Pte. Ltd., Baxter International Inc., Medtronic plc, Teleflex Incorporated, Axonics Modulation Technologies, Aveda Health, and Lucida Medical Ltd. Similarly, several partnerships took place between January 2018-June 2021. The aim of strategic partnerships includes new product development, strengthening of distribution network, and business expansion.

New product launches are one of the primary strategies adopted by new companies to enter in the global urology care devices and platforms market.Companies have also been working on upgrades for their existing products.

Between January 2018-June 2021, several new products were launched in the global urology care devices and platforms market.Companies such as Advanced MedTech Holdings Pte.

Ltd., B. Braun Melsungen AG, Teleflex Incorporated, and Stryker Corporation launched their products in the mentioned period. Furthermore, funding activities are critical for the entry and operation of start-ups in the global urology care devices and platforms market. Advanced MedTech Holdings is one of the prominent investors in the global urology care devices and platforms market that has regularly invested in various start-ups.

Two business models, namely, business to customer (B2C) and distributor network, are operational in the global urology care devices and platforms market.The device manufacturers often employ both the business models for ensuring a prominent local and global presence.

Advertisement
Stake.com

Furthermore, owing to the emergence of platforms companies enabling remote patient monitoring and improved imaging analytics, software-as-a-service (SaaS) is anticipated to become one of the prominent business models in the market.

The global urology care devices and platforms market report highlights that the market was valued at $13.61 billion in 2019 and is expected to reach $33.64 billion by the end of 2030. The market is expected to grow at a CAGR of 9.04% during the forecast period from 2021 to 2030.

Global Urology Care Devices and Platforms Market Drivers

The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions.The high susceptibility of diabetic patients to urinary tract infections (UTI) is a major factor for growing urological disorder cases.

Thus, with the rise in diabetic patients across the world, UTIs are becoming widespread.

Advertisement
Stake.com

There has been a shift in preference by urologists toward single use endoscopes as compared to reusables.This is due to the risk of contamination associated with reusable endoscopes.

Additionally, the usage of minimally invasive procedures as treatment for lower urinary tract symptoms (LUTS) has drastically increased since 2013.

Lastly, there have also been several key mergers and acquisitions in the field of urology that have driven the global urology care devices and platforms market. This assists the companies in gaining access to newer technologies and strengthening their product offering.

Global Urology Care Devices and Platforms Market Challenges

The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns.

Advertisement
Stake.com

While singe use instruments such as endoscopes have benefits that outweigh those of reusable devices, a major limitation encountered with single use instruments is their high upfront cost which puts pressure on the global urology care devices and platforms market.This causes an increase in hospital expenditure which subsequently leads to higher treatment costs.

As a result, healthcare becomes both less affordable and accessible.

Data breaches are a huge source of concern for healthcare organizations as such incidents can cause legal issues and increase the risk of the practice being shut down. Such cases negatively influence the global urology care devices and platforms market and thus, pose a hindrance to the growth of the market.

Global Urology Care Devices and Platforms Market Opportunities

The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.

Advertisement
Stake.com

Under the realm of telemedicine, telesurgery is one of the most challenging yet promising areas.Technological advancement and the development of high-speed internet with a wide bandwidth have positively influenced the field of telesurgery and telesurgical monitoring.

While telesurgery holds potential in the field of global urology care devices and platforms market, it is advancement in telecommunication technologies that will allow telesurgery’s applications in the field of education as well as assistance in urological procedures.

With more companies venturing into developing products with novel technologies, there is increased competition among the players in the global urology care devices and platforms market.While the major players in the global urology care devices and platforms market hold a larger market share, newer start-ups are focusing on entering the market by launching products that integrate concepts like artificial intelligence AI and machine learning (ML) into their devices.

This gives them an edge over the already existing products.

There are a number of remote patient monitoring devices in the global urology care devices and platforms market currently, such as CarePath by I-O Urology, CarelogiQ by CareLogiQ Corp, and KidneyIntelX by Renalytix AI plc, s. The demand for the devices is projected to grow in the future owing to the growing preference among patients and physicians, continuous patient monitoring, improvement in the decision-making process, and accelerated prognosis and treatment planning.

Advertisement
Stake.com

Impact of COVID-19 on Global Urology Care Devices and Platforms Market

In the short term, i.e., 2-4 years from 2020, COVID-19 would have a high impact on the global urology care devices and platforms market. The demand for remote patient monitoring devices is anticipated to be highest during this timeframe.

5-10 years from 2020, the resumption of elective surgeries and normalization of the supply chain would be the key factors for market recovery. Finally, in the long term, i.e., 8-12 years from 2020, the supply chain, production, and installation of conventional and advanced urology care devices are anticipated to be normalized.

Market Segmentation

Global Urology Care Devices and Platforms Market (by Product)

Advertisement
Stake.com

The global urology care devices and platforms market (by product) is segmented into conventional and advanced devices as well as platforms.The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems.

Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.

Global Urology Care Devices and Platforms Market (by Application)

The global urology care devices and platforms market (by application) is segmented into treatment, and diagnostics and monitoring.In terms of opportunities, the global urology care devices and platforms market holds significant growth potential for the diagnosis and monitoring segment.

The shifting preference from at-clinic to at-home diagnostic and monitoring services presents abundant opportunities for the segment.

Advertisement
Stake.com

Global Urology Care Devices and Platforms Market (by End User)

The global urology care devices and platforms market (by end user) is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics, dialysis centers, and home care settings.In terms of end user, the global urology care devices and platforms market holds significant growth opportunities in ASCs and homecare settings segment.

This is owing to the growing prevalence of urological conditions, rise in adoption of remote patient monitoring devices, and rising demand for homecare. However, the predominance of hospitals and clinics is anticipated to continue during the forecast period 2021- 2030.

Global Urology Care Devices and Platforms Market (by Indication)

The global urology care devices and platforms market (by indication) is segmented into kidney diseases, urological cancer and benign prostatic hyperplasia, pelvic organ prolapse, and other diseases.The global urology care devices and platforms market holds significant potential in urological disorders such as kidney diseases, benign prostatic hyperplasia (BPH), bladder cancer, prostate cancer, and urinary incontinence.

Advertisement
Stake.com

The rising prevalence of kidney diseases is attributed to factors such as a sedentary lifestyle, an unhealthy diet, and genetics. There are several conventional as well as advanced devices and platforms indicated to diagnose, treat, and monitor these urological disorders.

Global Urology Care Devices and Platforms Market (by Region)

The different regions covered under the global urology care devices and platforms market report include North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America dominated the global urology care devices and platforms market in 2019 and is anticipated to uphold its dominance throughout the forecast period.The growth in the market is majorly driven by the increasing research and development activities and large-scale adoption of global urology care devices and platforms.

Also, the ongoing trend for digital transformation through the development of platforms and mobile applications is putting a significant impact on the market growth.

Advertisement
Stake.com

Key Market Players and Competition Synopsis

Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, and Urologix, LLC.

The global urology care devices and platforms market has witnessed several strategic and technological developments in the past few years, undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are regulatory and legal activities, partnerships and alliances, new offerings, mergers and acquisitions, expansion activities, and funding activities.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• Spain
• U.K.
• Rest-of-Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia and New Zealand
• Rest-of-Asia-Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest-of-Latin America
• Middle East and Africa
• K.S.A.
• Israel
• South Africa
• Rest-of-Middle East and Africa (Rest-of-MEA)
Read the full report: https://www.reportlinker.com/p06124032/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Workers embrace AI and prioritise skills growth amid rising workloads and an accelerating pace of change: PwC 2024 Global Workforce Hopes & Fears Survey

Published

on

workers-embrace-ai-and-prioritise-skills-growth-amid-rising-workloads-and-an-accelerating-pace-of-change:-pwc-2024-global-workforce-hopes-&-fears-survey

Almost half (45%) of workers say their workload has increased significantly in the past year, as almost two-thirds (62%) say the pace of change at work has increased over the same timeMore than one-quarter (28%) say they are very or extremely likely to switch employer in the next 12 months – a higher proportion than during the ‘Great Resignation’ (19%) in 2022Employees prioritise skills-growth: fewer than half (46%) strongly or moderately agree that their employer provides adequate opportunities to learn new skills. This is particularly important for workers considering leaving: two-thirds (67%) say opportunities to learn new skills are a key factor in any decision to job-switchMore than 80% of workers who use generative AI daily expect it to make their time at work more efficient in the next 12 months. Half (49%) of all users expect it to lead to higher salariesCost-of-living pressures ease slightly: the proportion of workers with money left over each month rises to 45% (compared to 38% in 2023). However, 52% say they are still financially stressedLONDON, June 25, 2024 /PRNewswire/ — Among more than 56,000 workers across 50 countries and territories, many say they are prioritising long-term skills growth to accelerate their careers amid rising workloads and heightened workplace uncertainty, according to PwC’s 2024 Global Workforce Hopes & Fears Survey, published today.

In the last 12 months, workers say they have experienced rising workloads (45%) and an accelerating pace of workplace change. Nearly two-thirds (62%) say they have experienced more change at work in the past year than the 12 months prior, with two-fifths (40%) noting their daily responsibilities have changed to a large or very large extent. Almost half (44%) don’t understand the purpose of changes taking place.
In the midst of this growing mix of employee pressures, the findings suggest workers are alert to opportunities elsewhere, and are highly focused on skills growth and embracing AI.
More than one-quarter (28%) say they are likely to switch employer in the next 12 months, a percentage far higher than during the ‘Great Resignation’ (19%) of 2022. Two-thirds (67%) of those considering moving say skills is an important factor in their decision to stay with their current employer or switch to a new one.
Carol Stubbings, Global Markets and Tax & Legal Services (TLS) Leader, PwC UK, said:
“As workers face heightened uncertainty, rising workloads and continue to face financial stress, they are prioritising skills growth and embracing new and emerging technologies such as GenAI to turbocharge their growth and accelerate their careers. The findings suggest that job satisfaction is no longer enough. Employees are placing an increased premium on skills growth in a climate characterised by constant technological change. Employers must ensure they are investing in their employees and technological platforms to mitigate employee pressures and retain the brightest talent.”
Workers embrace AI to ease workplace pressures and unlock personal growth
As employees face heightened workplace pressures, they are also turning to new and emerging technologies such as generative AI (GenAI) to help. Among those employees who use GenAI daily, 82% expect it to make their time at work more efficient in the next 12 months.
Employees are also optimistic about opportunities for GenAI to support their growth. Half (49%) of all users expect GenAI to lead to higher salaries – an expectation that’s even higher (76%) among employees who use the technology daily. More than 70% of users agree that GenAI tools will create opportunities to be more creative at work (73%) and improve the quality of their work (72%).
The skills imperative
Workers are placing an increased premium on skills growth to mitigate their concerns and accelerate their careers. Employees who say they are likely to switch employers in the next 12 months are nearly twice as likely to strongly consider upskilling in that decision than workers planning to stay (67% vs. 36%). This comes as fewer than half (46%) of all employees moderately or strongly agree that their employer provides adequate opportunities to learn new skills that will be helpful to their careers.
Employees who are likely to leave in the next year may be more attuned to skills changes that are needed than the general workforce, with 51% moderately or strongly agreeing that the skills their job requires will change in the next five years (vs. 29% of those unlikely to change employer).
There is particular interest in the impact of AI on skills development, with 76% of all users expecting it to create opportunities to learn new skills at work. However, employers will need to invest heavily in new and emerging technology training and access. Among employees who have not used GenAI at work in the last 12 months, one-third (33%) don’t think there are opportunities to use the technology in their line of work, while 24% don’t have access to the tools at work, and 23% don’t know how to use the tools.
Despite the pace of change, there are also signs of optimism and engagement at work. 60% of workers expressed at least moderate job satisfaction (up from 56% in 2023) while more than half (57%) of employees who view fair pay as important agree that their job is fairly paid. Cost-of-living pressures have slightly eased since 2023 (the proportion of workers with money left over each month has risen to 45%, up from 38%). However,  more than half (52%) say they are still financially stressed to some degree.
Pete Brown, Global Workforce Leader, PwC UK, said:
“Technology is fundamentally transforming the way work gets done and the types of skills employers are looking for. Employees are therefore placing an increased premium on organisations that invest in their skills growth so that they can stay relevant and thrive in a digital world. Businesses in turn must be proactive in their upskilling programs – prioritising the employee experience and being transparent. Because when you meaningfully engage your workforce, they become an accelerant for successful transformation.”
Notes to Editors: 
About the Survey
In March 2024, PwC surveyed 56,600 individuals across 50 countries and territories who are in work or active in the labour market. The sample was designed to reflect a range of industries, demographic characteristics and working patterns. You can read the full report on pwc.com.
About PwC
© 2024 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.
Contact:  Imran Javaid, Global Corporate Affairs and Communications, PwC UK: [email protected] Dan Barabas, Global Corporate Affairs and Communications, PwC UK: [email protected]
Logo – https://mma.prnewswire.com/media/1121790/PWC_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/workers-embrace-ai-and-prioritise-skills-growth-amid-rising-workloads-and-an-accelerating-pace-of-change-pwc-2024-global-workforce-hopes–fears-survey-302180793.html

Continue Reading

Artificial Intelligence

Amagi Showcases New Stream Technology With VIZIO

Published

on

amagi-showcases-new-stream-technology-with-vizio

Amagi’s new Zero Slate delivers personalized linear streaming, resulting in increased viewership on VIZIO FAST channels 
NEW YORK, June 24, 2024 /PRNewswire/ — Amagi, the global leader in cloud-based SaaS technology for broadcast and Connected TV (CTV), today announced the first successful showcase of Amagi’s Zero Slate technology on VIZIO’s owned and operated WatchFree+ channels, part of Amagi’s broader Stream Personalization initiative. This innovative new offering enhances the streaming experience with its highly impactful, patent-pending technology that can dynamically adjust the length of ad breaks on a per-viewer basis, eliminating the need for slates or filler to round out linear ad breaks.

This new “viewer-first” personalized approach to digital streaming has already demonstrated a lift in viewership (Amagi ANALYTICS showing more than 20% increase) on VIZIO’s owned and operated channels utilizing the Zero Slate capabilities. This industry-first innovation from Amagi paves the path for a more engaging and profitable future for entertainment and enhanced viewer experiences.
Data from Amagi ANALYTICS indicates that slates, often used to fill the unsold portion of ad pods, may increase viewer churn by as much as 15% in today’s Free Ad-supported Streaming TV (FAST) ecosystem. Zero Slate’s early success demonstrates that personalizing pod length can boost viewer engagement, enabling more high-quality viewing experiences over time. This capability also represents an important first step for Amagi toward a broader suite of Stream Personalization capabilities that offer even more engaging linear viewing experiences.
“We are pleased to partner with Amagi on this showcase of their Zero Slate technology. This collaboration reinforces VIZIO’s commitment to enhancing user experiences and delivering personalized content as we expand Zero Slate across more channels,” said Katherine Pond, Group Vice President of Platform Content and Partnerships at VIZIO.
“We are grateful to have partnered with an industry leader like VIZIO to test the impact of our new Zero Slate capability and are excited about Stream Personalization’s ability to further transform the linear viewing experience,” said Srinivasan KA, Co-founder and Chief Revenue Officer, Amagi.
About VIZIOFounded and headquartered in Orange County, California, our mission at VIZIO Holding Corp. (NYSE: VZIO) is to deliver immersive entertainment and compelling lifestyle enhancements that make our products the center of the connected home. We are driving the future of televisions through our integrated platform of cutting-edge Smart TVs and powerful operating system. We also offer a portfolio of innovative sound bars that deliver consumers an elevated audio experience. Our platform gives content providers more ways to distribute their content and advertisers more tools to connect with the right audience.
For more information, visit VIZIO.com and follow VIZIO on Facebook, Twitter, and [email protected] 
About AmagiAmagi is a next-generation media technology company that provides cloud broadcast and targeted advertising solutions to broadcast TV and streaming TV platforms. Amagi enables content owners to launch, distribute, and monetize live linear channels on Free Ad-supported Streaming TV and video services platforms. Amagi also offers 24×7 cloud-managed services bringing simplicity, advanced automation, and transparency to the entire broadcast operations. Overall, Amagi supports 800+ content brands, 800+ playout chains, and over 5,000 channel deliveries on its platform in over 150 countries. Amagi has a presence in New York, Los Angeles, London, Paris, Melbourne, Seoul, Singapore, and broadcast operations in New Delhi, and innovation centers in Bengaluru, Zagreb, and Łódź.
Link to Word Doc: www.wallstcom.com/Amagi/240624-Amagi-VIZIO_ZSlate.docx 
Agency Contact:Joseph LesieutreWall Street CommunicationsEmail: [email protected]
Amagi Contact:Aashish WashikarDirector – Corporate CommunicationsEmail: [email protected]: +91 9533390005

View original content:https://www.prnewswire.co.uk/news-releases/amagi-showcases-new-stream-technology-with-vizio-302180925.html

Continue Reading

Artificial Intelligence

ResourceWise Brings Its Cross-Commodity Data and Analytics Expertise to New Oleochemicals Service

Published

on

resourcewise-brings-its-cross-commodity-data-and-analytics-expertise-to-new-oleochemicals-service

ResourceWise has met a key milestone in providing cross-commodity price benchmarks, data, and analysis on chemicals, forest products, and decarbonization markets. 
CHARLOTTE, N.C., June 24, 2024 /PRNewswire/ — ResourceWise has met a key milestone in providing cross-commodity price benchmarks, data, and analysis on chemicals, forest products, and decarbonization markets. 

For the first time, one digital product encompasses expertise that spans all the key commodity sectors that ResourceWise covers. Dedicated to renewable feedstock, the new platform-based oleochemicals analysis and insight tools draw on decades of experience within each distinct business sector. 
Dwight Lynch, Biomaterials Business Manager at ResourceWise, is leading the transition towards data and insight on renewable intermediates and biobased and biodegradable polymer inputs. 
“Navigating oleochemicals markets at a time when regulation, legislation, and competition from renewable fuels markets are the key drivers is a challenge. Our new service offers pricing and analysis that informs decision-makers and allows sustainable business to thrive.” 
The new oleochemicals portal in ResourceWise’s flagship chemicals market intelligence platform, OrbiChem360, has evolved beyond its legacy biomaterials insights to focus on the fats and oils markets that are key to sustainability.  
It presents pricing data and analysis that ResourceWise biomaterials experts have furnished within OrbiChem360 this past decade and includes a crude tall oil (CTO) price index. The inclusion of a forest-based output introduces the ResourceWise platform FisherSolve’s pulp and paper industry insight to our portfolio. 
Pete Stewart, the CEO of ResourceWise, is focused on the future. “From raw material converters to end-use consumer goods producers, manufacturing value chain participants are increasingly seeking cross-commodity insights to meet low-carbon targets. We are building and providing the data and analytics businesses need to achieve environmental, social, and governance (ESG) targets and market products competitively worldwide.  
“The ResourceWise mission is to use the intelligence within the increasingly inter-related business sectors we have harnessed to guide customers in their journey toward a net-zero future. This new offering is the first of many milestones in our endeavor to do just that,” adds Stewart.  
A Streamlined Renewable Chemicals Service  
The new product leverages oleochemical pricing and commentary gathered by ResourceWise legacy brands since 2014 and insight collected since the 1990s. It extends our regional reach with additional price points and streamlines the data and analytics provided.  
The new portal is designed with personal care, cosmetics, detergents, lubricants, pharmaceuticals, flavor and fragrance, and food and beverage market participants in mind. However, it provides pricing data and insights for producers, intermediaries, and consumer product manufacturers in broader industries. 
More Than Forty Current and Historical Prices          
International price indexes for oleochemicals include the feedstocks soybean, coconut, tall, rapeseed, and palm oils, as well as tallow and glycerine grades Dozens of spot and contract prices for fatty acids and fatty alcohols plus comprehensive commentary based on intelligence from a worldwide contact base       Low-carbon price benchmarks and commentary in our oleochemicals offering will increasingly leverage intelligence on the biofuels sector within the Prima CarbonZero platform      Global Trade Flow graphics for all oils and tallow to help customers understand how key plant and animal-based feedstocks are traded globally to identify new markets and sources   Industry experts contextualize data, making it actionable, and respond personally to customer inquiries By bridging information gaps in the chemicals market, OrbiChem360 subscribers gain a competitive edge in volatile markets. The platform provides decision makers with robust, data-driven insight that unravels market trends so they can harness growth opportunities. For more information on the OrbiChem360 platform, visit the ResourceWise OrbiChem360 page. 
CONTACT:
Contact:Suz-Anne Kinney          Vice President, Marketing & Communications at [email protected]  +1 (980) 233-4021
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/resourcewise/r/resourcewise-brings-its-cross-commodity-data-and-analytics-expertise-to-new-oleochemicals-service,c4005742

View original content:https://www.prnewswire.co.uk/news-releases/resourcewise-brings-its-cross-commodity-data-and-analytics-expertise-to-new-oleochemicals-service-302180514.html

Continue Reading

Trending